EUVIMEDEUVIMED entdecken
Querschnittstudie

Assessment of QTc-interval Prolonging Medication Utilization and Associated Potential Drug-Drug Interactions in Hospitalized Cardiac Patients: A Cross-Sectional Study in Cardiology

Ahmad Ullah Humza, Afshan Siddiq, Sadia Ghousia Baig, Asif Ali, Imran Ahmed, Jibran Bin Yousuf

Jordan Journal of Pharmaceutical Sciences · 24.09.2024 · 17 (3) · 603-610

DOI: 10.35516/jjps.v17i3.2136 ↗

Kurz gefasst

Querschnittstudie in der Zeitschrift Jordan Journal of Pharmaceutical Sciences, online erschienen am 24.09.2024. Verfasst von Ahmad Ullah Humza und 5 weiteren Autor:innen. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 27 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Several medications are linked to QTc-interval prolongation and torsades de pointes (TdP), a risk that is more common among hospitalized patients due to polypharmacy and associated QTc-interval-prolonging drug-drug interactions (QTc-pDDIs).

Objective

This study aimed to identify the prevalence of QTc-interval-prolonging drug (QTc-Drug) utilization and QTc-pDDIs among postoperative cardiac patients admitted to the National Institute of Cardiovascular Diseases (NICVD).

Method

We conducted a cross-sectional study at the NICVD, reviewing patients' medication charts for the use of QTc-Drugs and QTc-pDDIs. The CredibleMeds list was used to identify drugs associated with QTc-interval prolongation, while Micromedex Drug-Int.® and Lexicomp Interact® were utilized to screen for QTc-pDDIs.

Results

A total of 384 patients, with an average age of 48.9 ± 13.9 years, were included in the study. On average, patients used 10.3 ± 1.7 medications. Of the 3,956 medications prescribed, 22.9% were QTc-Drugs. The most frequently used QTc-Drug classes were diuretics (69.3%), anti-emetics (61.5%), and proton pump inhibitors (51.0%). Overall, 99.7% of patients received at least one QTc-Drug. The most frequent QTc-pDDI was ciprofloxacin-domperidone (7.6%), classified as major by Micromedex and a category B interaction by Lexicomp.

Conclusion

The prevalence of QTc-Drugs was very high among postoperative cardiac patients, with nearly all patients (99.7%) receiving at least one QTc-Drug. The most common QTc-pDDI was ciprofloxacin-domperidone (7.6%), identified as a major interaction by Micromedex and a category B interaction by Lexicomp. Category X (contraindicated) QTc-pDDIs should be avoided in hospitalized patients.

Zitieren

APA

Humza, A. U., Siddiq, A., Baig, S. G., Ali, A., Ahmed, I., & Yousuf, J. B. (2024). Assessment of QTc-interval Prolonging Medication Utilization and Associated Potential Drug-Drug Interactions in Hospitalized Cardiac Patients: A Cross-Sectional Study in Cardiology. Jordan Journal of Pharmaceutical Sciences, 17(3), 603-610. https://doi.org/10.35516/jjps.v17i3.2136

Vancouver

Humza AU, Siddiq A, Baig SG, Ali A, Ahmed I, Yousuf JB. Assessment of QTc-interval Prolonging Medication Utilization and Associated Potential Drug-Drug Interactions in Hospitalized Cardiac Patients: A Cross-Sectional Study in Cardiology. Jordan Journal of Pharmaceutical Sciences. 2024;17(3):603-610. doi:10.35516/jjps.v17i3.2136

BibTeX
@article{Humza2024,
  author = {Humza, Ahmad Ullah and Siddiq, Afshan and Baig, Sadia Ghousia and Ali, Asif and Ahmed, Imran and Yousuf, Jibran Bin},
  title = {Assessment of QTc-interval Prolonging Medication Utilization and Associated Potential Drug-Drug Interactions in Hospitalized Cardiac Patients: A Cross-Sectional Study in Cardiology},
  journal = {Jordan Journal of Pharmaceutical Sciences},
  year = {2024},
  volume = {17},
  number = {3},
  pages = {603--610},
  doi = {10.35516/jjps.v17i3.2136}
}
Kostenlos starten →